Acumen Pharmaceuticals (ABOS) Selling, General & Administrative (2020 - 2026)
Acumen Pharmaceuticals (ABOS) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - | 2.17 Mn |
| 3 | BeOne Medicines | 472.86 Bn | 468.07 Bn | 1.35 Bn | 555.10 Mn |
| 4 | Vertex Pharmaceuticals | 123.71 Bn | 116.47 Bn | 2.59 Bn | 493.70 Mn |
| 5 | Regeneron Pharmaceuticals | 71.61 Bn | 62.86 Bn | 3.31 Bn | 647.70 Mn |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - | 17.02 Mn |
| 7 | Argenx Se | 54.62 Bn | 49.44 Bn | 1.41 Bn | 1.13 Bn |
| 8 | Alnylam Pharmaceuticals | 38.09 Bn | 35.08 Bn | 959.66 Mn | 322.55 Mn |
| 9 | Revolution Medicines | 36.08 Bn | 36.08 Bn | - | 101.25 Mn |
| 10 | Acumen Pharmaceuticals | 143.19 Mn | 143.19 Mn | - | 4.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.67 Mn |
| Dec 31, 2025 | 4.67 Mn |
| Sep 30, 2025 | 4.55 Mn |
| Jun 30, 2025 | 4.63 Mn |
| Mar 31, 2025 | 5.10 Mn |
| Dec 31, 2024 | 5.03 Mn |
| Sep 30, 2024 | 5.02 Mn |
| Jun 30, 2024 | 4.85 Mn |
| Mar 31, 2024 | 5.33 Mn |
| Dec 31, 2023 | 5.19 Mn |
| Sep 30, 2023 | 4.86 Mn |
| Jun 30, 2023 | 4.35 Mn |
| Mar 31, 2023 | 4.42 Mn |
| Dec 31, 2022 | 3.50 Mn |
| Sep 30, 2022 | 3.06 Mn |
| Jun 30, 2022 | 3.09 Mn |
| Mar 31, 2022 | 3.22 Mn |
| Dec 31, 2021 | 2.74 Mn |
| Sep 30, 2021 | 2.14 Mn |
| Jun 30, 2021 | 1.19 Mn |